Clinical trial
URSa-1: A Minibasket Study of Pembrolizumab in Ultra-Rare Sarcomas
NCT07089992 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- URSa-1: A Minibasket Study of Pembrolizumab in Ultra-Rare Sarcomas
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- December 4, 2025
- Completion date
- December 31, 2028
- Enrollment
- 32 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.